MYGN
Market read
No new filing conclusion is available. 0 of 10 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 15 directly disclosed connections are confirming.
Invalidation: The isolated read changes if MYGN's group or a disclosed connection begins moving with it.
Research brief
No new filing conclusion is available. 0 of 10 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 15 directly disclosed connections are confirming.
No thresholded supportive filing evidence is available yet.
No thresholded adverse filing evidence is available yet.
Company research
Use the company’s filings to identify the few operating, demand, cost, capital and regulatory variables that determine its earnings power.
Reported annual revenue and per-share history. This is accounting history, not a forecast.
What management says matters
“The following table represents the balances of cash and cash equivalents as of the dates set forth in the table below: (in millions) June 30, 2026 December 31, 2025 Change Cash and cash equivalents $ 115.2 $ 149.6 $ (34.4) The decrease in cash and cash equiva…”10-Q · Jul 31, 2026 ↗
“Cash Flows from Financing Activities Cash flows from financing activities decreased $17.0 million for the six months ended June 30, 2026 compared to the same period in the prior year, primarily due to incremental borrowings of $19.5 million under our previous…”10-Q · Jul 31, 2026 ↗
“The increase in Mental Health revenue per test was due to increased reimbursement, which offset the unfavorable changes in estimates associated with aged orders recognized during the period.”10-Q · Jul 31, 2026 ↗
“68 Table of Contents Research and Development Expense Years ended December 31, (in millions) 2025 2024 Change % Change Research and development expense $ 106.8 $ 113.4 $ (6.6) (6) % Research and development expense as a % of total revenue 13.0 % 13.5 % Resear…”10-K · Feb 24, 2026 ↗
Valuation discipline
Price/sales 0.4× · EV/sales 0.3×. Comparisons use only industry-matched filing peers.
Mechanical 2.0-year scenarios are available as editable assumptions, not consensus.
Price action
Jodie does not have enough daily observations to draw a useful short-term chart for this asset. The latest quoted price was checked 10 Sept, 15:55 GMT-4; this is a coverage limitation, not a flat-price conclusion.
Developments
Jodie has not returned a relevant primary source or news item for MYGN. This is an evidence-coverage gap, not a conclusion that nothing material happened.
Business and financial condition
Jodie has not returned structured SEC XBRL fundamentals for this asset. This is a coverage limitation, not an assessment of the business or its financial health.
Filing analysis
Jodie has not yet found a suitable current-versus-prior filing comparison for MYGN. This does not mean the latest filing was neutral or immaterial.
Business ecosystem
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
“In September 2025, we entered into a strategic collaboration with SOPHiA GENETICS S.A.”
“Our competitors in women's health include Natera, Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, BillionToOne, Inc., Tempus AI, Inc., Fulgent Genetics, Inc., and Peekaboo Early Detection Gender DNA Test.”
Depended on by
“Other companies offering testing in the precision oncology industry include Illumina, NeoGenomics, Myriad Genetics, Laboratory Corporation of America, Quest Diagnostics, and BostonGene.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 17 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
MYGN is currently a Follower in the organic co-movement group Media & Financial Services. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for MYGN; it is not active in the latest market snapshot.
Context history
No durable theme membership has been observed for this name yet.